Saturn V Capital Management as of March 31, 2025
Portfolio Holdings for Saturn V Capital Management
Saturn V Capital Management holds 21 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 15.7 | $31M | 199k | 155.86 | |
| Disc Medicine (IRON) | 13.0 | $26M | 518k | 49.64 | |
| Cg Oncology (CGON) | 7.1 | $14M | 578k | 24.49 | |
| Xenon Pharmaceuticals (XENE) | 7.0 | $14M | 414k | 33.55 | |
| Merus N V (MRUS) | 6.9 | $14M | 323k | 42.09 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 6.8 | $13M | 344k | 39.07 | |
| Syndax Pharmaceuticals (SNDX) | 6.5 | $13M | 1.0M | 12.29 | |
| Celcuity (CELC) | 5.6 | $11M | 1.1M | 10.11 | |
| Cogent Biosciences (COGT) | 4.5 | $8.9M | 1.5M | 5.99 | |
| Vaxcyte (PCVX) | 4.4 | $8.8M | 232k | 37.76 | |
| Amylyx Pharmaceuticals (AMLX) | 4.3 | $8.6M | 2.4M | 3.54 | |
| Argenx Se Sponsored Adr (ARGX) | 4.1 | $8.2M | 14k | 591.87 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 3.3 | $6.5M | 449k | 14.38 | |
| Ocular Therapeutix (OCUL) | 2.2 | $4.4M | 598k | 7.33 | |
| Contineum Therapeutics Cl A (CTNM) | 2.0 | $3.9M | 561k | 6.98 | |
| Abivax Sa Sponsored Ads (ABVX) | 1.7 | $3.5M | 553k | 6.25 | |
| Kalvista Pharmaceuticals (KALV) | 1.5 | $2.9M | 255k | 11.54 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 1.2 | $2.4M | 116k | 20.47 | |
| Silence Therapeutics Ads (SLN) | 1.0 | $2.1M | 733k | 2.82 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.0 | $2.0M | 59k | 33.54 | |
| Inozyme Pharma (INZY) | 0.2 | $454k | 499k | 0.91 |
